Investigator
Tim Lahm
NATIONAL JEWISH HEALTH · funded by NHLBI, VA
- Companies
- 2
- Grants
- 5
- Non-dilutive funding
- $1.1M
- First award
- Jan 1, 2014
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jun 1, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- NATIONAL JEWISH HEALTHMomentum in another area
ImmunologyGrant-only
- NATIONAL JEWISH HEALTHMomentum in another area
ImmunologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R13
Pulmonary Vascular Disease: The Vascular Niche and its Interactions in Lung Homeostasis and Disease
$30kJun 1, 2026NHLBINATIONAL JEWISH HEALTHNIH RePORTER · 11390961 (opens the source filing in a new tab)
- P01
Androgen signaling in asthma
$354kAug 1, 2021NHLBIINDIANA UNIVERSITY INDIANAPOLISNIH RePORTER · 11085935 (opens the source filing in a new tab)
- R01
Mechanisms of right ventricle adaptation to pulmonary hypertension
$726kSep 1, 2019NHLBINATIONAL JEWISH HEALTHNIH RePORTER · 11192285 (opens the source filing in a new tab)
- I01
Estrogen Receptor-alpha Effects on Right Ventricular Vascular Density and Angiogenesis in Pulmonary Hypertension
Jan 1, 2014VAVA EASTERN COLORADO HEALTH CARE SYSTEMNIH RePORTER · 10804445 (opens the source filing in a new tab)
- I01
Estrogen Receptor-alpha Effects on Right Ventricular Vascular Density and Angiogenesis in Pulmonary Hypertension
Jan 1, 2014VAVA EASTERN COLORADO HEALTH CARE SYSTEMNIH RePORTER · 11258402 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources